Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance

BACKGROUND: Arylamine N-acetyltransferase 1 (NAT1) is a drug metabolizing enzyme that has been associated with cancer cell proliferation in vitro and with survival in vivo. NAT1 expression has been associated with the estrogen receptor and it has been proposed as a prognostic marker for estrogen rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Minchin, Rodney F., Butcher, Neville J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029418/
https://www.ncbi.nlm.nih.gov/pubmed/29969986
http://dx.doi.org/10.1186/s12864-018-4894-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029418/
https://www.ncbi.nlm.nih.gov/pubmed/29969986
http://dx.doi.org/10.1186/s12864-018-4894-4

Ejemplares similares